Argus Research analyst John Staszak downgrades Nike (NYSE:NKE) from Buy to Hold.
Benchmark Maintains Buy on Plexus, Raises Price Target to $105
Benchmark analyst David Williams maintains Plexus (NASDAQ:PLXS) with a Buy and raises the price target from $101 to $105.